Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients (MK0653A-168)

• Status: Terminated
• Trial end date: 2010-08-01
• Target enrollment: 0
• Participant gender: All

Summary

Evaluate pleiotropic effects of simvastatin in hypertensive patients.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fundación Lindavista del Corazón AC
• Treatments: Ezetimibe; Pravastatin; Simvastatin; Valsartan

Criteria

Inclusion Criteria:

• Females Or Males Over 18 Years Old

• Patients With Systemic Arterial Hypertension Grade I And II According With The European Society Of Cardiology

• Left Ventricular hypertrophy Demonstrated By Echocardiography

• Mild To Moderated hypercholesterolemia

• Willing To Participate And Sign The Informed Consent Form (ICF)

Exclusion Criteria:

• Type 1 Or 2 Diabetes Mellitus

• Familiar hypercholesterolemia

• Low Density Lipoprotein-Cholesterol (LDL-C) > 190 mg/dl

• History Of Myocardial Infarction Or Stable Chronic Angina

• Triglycerides >250 mg/dl